Dr. Hope Rugo and advocate Jonise Louis discuss new ADCs, biomarker testing, and patient-centered dosing for metastatic ...

A couple shares how open communication reshaped their relationship during and after liver cancer treatment. Paul McKenzie, a liver cancer survivor, and his wife, Emma, sat down with CURE for a ...

As of 2025, there are over 18.6 million cancer survivors in the United States, representing about 1 in 18 Americans. By the ...

Patients with cancer treated at Mayo Clinic in Jacksonville, Florida safely received intravenous chemotherapy in their homes through a pilot program designed to reduce the burden of treatment while ...

For many, a diagnosis of stage 4 metastatic breast cancer can feel like a closing chapter. But for Casey Liening, diagnosed at age 32 after a grueling two-year battle to have her ...

Paul, a liver cancer survivor, and his wife Emma share their journey of recovery, caregiving and finding balance in life ...

Frontline nivolumab plus AVD reduced risk of progression or death by 58% versus brentuximab vedotin plus AVD (PFS HR, 0.42) in advanced-stage classical Hodgkin lymphoma. CA209-8UT randomized 994 ...

Earlier-line bispecific therapy leverages lower disease refractoriness to drive deeper, more durable responses than typically ...

Top experts share the latest bladder, kidney and prostate cancer advances from the 2026 ASCO GU Symposium, highlighting patient impact. At the 2026 ASCO GU meeting, experts gathered to share the ...

I was participating in a Drumming Clinical Study, which I really enjoyed. And I was so disappointed that I was unable to ...

Initially unfamiliar with the process, he quickly began to consider the possibility of helping his father directly. After reflecting on the situation, he described the decision to pursue testing as ...

A Decision Score provides prognostic discrimination for 10-year locoregional recurrence, with rising score associated with ...